Healthcare & Life Sciences Review 2017

Healthcare & Life Sciences Review 2017

Today, Singapore is home to more than 50 biomedical sciences manufacturing plants, producing a wide range of products ranging from drugs to medical devices and equipment, with a combined manufacturing output of more than $26 billion in 2014. With over 30 leading biomedical sciences companies basing their regional headquarters here, Singapore is also a key base for companies to access the fast-growing Asia-Pacific markets.

Download the report here

Share This Post
Share on facebook
Share on linkedin
Share on twitter
Share on email

Keep up with our Online Medtech Events in the midst of Covid-19

View our full listing of events and join us.